Breaking ground on translational stem cell research

Annals of the New York Academy of Sciences

Volumn 1189, Issue SUPPL. 1, 2010, Pages 1-15

  Hall, Zach W ^a   Kahler, David ^a   Manganiello, Michael ^a   Egli, Dieter ^a   James, Daylon ^a,b   Marlot, Darja ^a,c   Fasano, Christopher ^a,d   Ichida, Justin ^a,e   Noggle, Scott ^a   Solomon, Susan L ^a   McKeon, David ^a   Smith, Kristin ^a   Marshall, Caroline ^a  

^a New York Stem Cell Foundation   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d New York Neural Stem Cell Institute   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; INSULIN;

BLASTOCYST; BODY MASS; CLINICAL RESEARCH; CONFERENCE PAPER; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDODERM; GASTRULATION; HEALTH CARE POLICY; HEART; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INNER CELL MASS; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE; MYOBLAST; NERVE DEGENERATION; NEURAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; SPINAL CORD INJURY; STEM CELL; SUBVENTRICULAR ZONE; TISSUE REGENERATION; TROPHOBLAST; CYTOLOGY; METABOLISM; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH; UNITED STATES;

NEW YORK CITY; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSLATIONAL RESEARCH;

EID: 77953471644     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05412.x     Document Type: Conference Paper

References (54)

1. Trendelenburg, A. et al. 2009. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am. J. Physiol. Cell Physiol. 296 : C1258 C1270.
2. Tan, B. et al. 2006. The cancer stem cell hypothesis: a work in progress. Lab. Investig. 86 :1203 1207.
3. + cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2 : 165 179.
4. Trowbridge, J. et al. 2006. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 12 : 89 98.
5. Chen, S. et al. 2009. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5 : 258 265.
6. Vaxillaire, M. et al. 2008. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr. Rev. 29 : 254 564.
7. Eisenbarth, G. S. 2007. Update in type 1 diabetes. J. Clin. Endocrinol. Metab. 92 : 2403 2407.
8. Dor, Y. et al. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429 : 41 46.
9. Nir, T. et al. 2007. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117 : 2553 2561.
10. Burlison, J. S. et al. 2008. Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells. Dev. Biol. 316 : 74 86.
11. Fujitani, Y. et al. 2006. Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for PDx1 in forgut organ differentiation and pancreas formation. Genes Dev. 20 : 253 266.
12. Arner, E. et al. 2009. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59 : 105 109.
13. Lundgren, M. et al. 2007. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 50 : 625 633.
14. Xie, Y. et al. 2009. Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457 : 97 101.
15. Zhiching, L. et al. 2006. Understanding hematopoietic stem-cell microenvironments. Trends Biochem. Sci. 31 : 589 595.
16. Seandel, M. et al. 2008. Generation of a functional and durable vascular niche by the adenoviral EFORF1 gene. Proc. Natl. Acad. Sci. USA 105 : 19288 19293.
17. Seandel, M. et al. 2008. Generation of a functional and durable vascular niche by the adenoviral EFORF1 gene. Proc. Natl. Acad. Sci. USA 105 : 19288 19293. Ibid.
18. Jaiswal, S. et al. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138 : 271 285.
19. Jaiswal, S. et al. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138 : 271 285 Ibid.
20. Majeti, R. et al. 2009. Cd47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138 : 286 299.
21. Kattman, S. et al. 2006. Mutlipotent FlK-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell. 11 : 723 732.
22. + embryonic-stem-cell-derived population. Nature 453 : 524 528.
23. Chen, V. et al. 2008. Notch signaling respecifies the hemangioblast to a cardiac fate. Nat. Biotech. 26 : 1169 1178.
24. Freytes, D.O. et al. 2009. Geometry and force control of cell function. J. Cell. Biochem. 108 : 1047 1058.
25. Radisic, M. et al. 2008. Cardiac tissue engineering using perfusion bioreactor systems. Nat. Prot. 3 : 719 738.
26. Gerecht, S. et al. 2007. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 104 : 11298 11303. (Pubitemid 47175135)
27. O'Connor, M. et al. 2009. Differentiation rather than aging of stem cells abolishes their telomerase activity. Biotechnol. Prog. 25 : 1130 1137.
28. Carlson, M. I. Conboy. 2007. Loss of stem cell regenerative capacity within aged niches. Aging Cell 6 : 371 382.
29. Carlson, M. et al. 2008. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454 : 528 534.
30. Baumann, N. D. Pham-Dinh. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81 : 871 927.
31. Goldman, S. et al. 2008. Stem cell-based strategies for treating pediatric disorders of myelin. Hum. Molec. Genet. 17 : 76 83.
32. Goldman, S. S. Natesan. 2008. A niche-defying feat: induced oligoneogenesis in the adult dentate gyrus. Cell Stem Cell 3 : 125 126.
33. Desbordes, S. et al. 2008. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2 : 602 612.
34. Chambers, S. et al. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 : 275 280.
35. Chambers, S. et al. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 : 275 280. Ibid.
36. Lee, G. et al. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461 : 402 406.
37. Papapetrou, E. et al. 2009. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc. Natl. Acad. Sci. USA 106 : 12759 12764.
38. Lee, G. et al. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461 : 402 406.
39. Lim, D. et al. 2009. Chromatin remodelling factgor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 458 : 529 533.
40. Mirzadeh, Z. et al. 2008. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 3 : 265 278.
41. Kriegstein, A. A. Alvarez-Bullya 2009. The glial nature of embryonic and adult stem cells. Ann. Rev. Neuro. 32 : 149 184.
42. Zhou, H. et al. 2009. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 5 : 381 384.
43. Chen, S. et al. 2006. Self-renewal of embryonic stem cells by a small molecule. Proc. Natl. Acad. Sci. USA 103 : 17266 17271.
44. Shi, Y. et al. 2008. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3 : 568 574.
45. Li, W. et al. 2009. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4 : 16 19.
46. Navarro, P. et al. 2008. Molecular coupling of Xist regulation and pluripotency. Science 321 : 1693 1695.
47. Navarro, P. et al. 2008. Molecular coupling of Xist regulation and pluripotency. Science 321 : 1693 1695 Ibid.
48. Navarro, P. et al. 2008. Molecular coupling of Xist regulation and pluripotency. Science 321 : 1693 1695 Ibid.
49. Lu, R. et al. 2009. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462 : 358 362.
50. Ichida, J. et al. 2009. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5 : 491 503.
51. Rossant, J. 2008. Stem cells and early lineage development. Cell 132 : 527 531.
52. Dietrich, J. T. Hiiragi. 2007. Stochastic patterning in the mouse pre-implantation embryo. Development 134 : 4219 4231.
53. Rossant, J. 2009. PL-03 Signaling pathways in blastocyst lineage development. Mech. Dev. 126 : S3 S3.
54. Nishioka, N. et al. 2009. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16 : 398 410.